Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now early-phase tilt small index

Nausea and Vomiting: early-phase trial registry

2 of 8 indexed Nausea and Vomiting trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #2,176 of 28,707 conditions by registered trial count.

8 US clinical trials · 2 currently recruiting · #2,176 of 28,707 conditions by registered trial count

Nausea and Vomiting: 8 US clinical trials tracked, 2 recruiting.

Nausea and Vomiting is the subject of 8 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most active sponsor is Heron Therapeutics, running 1 of these trials.

Enrollment posture brief

Registry condition nausea-and-vomiting

OPEN 2 | RECR 25% | LATE 2 | EARLY 4 | RANK #2176 | SPON 1

Nearest open-share peer: Abdominal Pain (25% recruiting · 20 trials)

Activity, Motor75%Achalasia50%Abdominal Cancer25%Acne Scars - Mixed Atrophic 25%Nausea and Vomiting (this)25%
Open-enrollment share among volume-matched conditions near Nausea and Vomiting

Nausea and Vomiting lists 2 open slots (25% of 8 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Nausea and Vomiting on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Nausea and Vomiting is recruiting below its size-band peers.

    2 of 8 indexed trials (25%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Nausea and Vomiting trials is spread across many organizations.

    Heron Therapeutics accounts for 1 of 8 trials (12.5%). 8 distinct sponsors appear on at least one study for this condition label.

  3. Typical Nausea and Vomiting enrolment sits around 125 participants.

    Median target enrolment is 125 among the 7 trials that report a genuine target (sentinel values excluded). 3 of those (42.9%) plan for fewer than 100 participants.

  4. Nausea and Vomiting research is mostly interventional.

    8 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 11Phase 23Phase 32

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 2 3
Phase 3 2

Named interventions

Most-linked intervention names on Nausea and Vomiting records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

aprepitant Drug
2 trials
dexamethasone Drug
2 trials
placebo Other
2 trials
fatigue assessment and management Procedure
1 trials
ondansetron Drug
1 trials
Palonosetron Hydrochloride Drug
1 trials
APF530 Drug
1 trials
Prochlorperazine Drug
1 trials

US sites by state

Facility locations filed on Nausea and Vomiting trials. A trial with sites in several states counts in each.

Georgia 3 trials
Texas 2 trials
New York 2 trials
North Carolina 2 trials
Illinois 2 trials
California 2 trials
Oregon 1 trials
New Jersey 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Nausea and Vomiting page

8 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 2 Nausea and Vomiting trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Heron Therapeutics sponsors the most Nausea and Vomiting trials on record, review their full trial history before evaluating a specific study. See Heron Therapeutics's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Nausea and Vomiting condition card totals 8 registered trials; most-linked intervention aprepitant; top US site state Georgia. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.